CLDN5 and stroke disorder: After 24 h pMCAo, the fluorescence intensity of Claudin-5 and ZO-1 presented weak and unclear in BMV from ischemic cortex post-stroke, while partly salvaged by BMSC-EVs and BEC-EVs treatments (Fig. 4A).